Ascorbic acid: Its role in immune system and chronic inflammation diseases

Mini-Reviews in Medicinal Chemistry

Volumn 14, Issue 5, 2014, Pages 444-452

  Sorice, Angela ^a   Guerriero, Eliana ^a   Capone, Francesca ^a   Colonna, Giovanni ^a   Castello, Giuseppe ^b   Costantini, Susan ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antinflammatory role; Antiviral role; Ascorbic acid; Chronic diseases; Immune system; Inflammation

Indexed keywords

ASCORBIC ACID; IMMUNOGLOBULIN; ANTIOXIDANT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; CANDIDA ALBICANS; CELIAC DISEASE; CELL PROLIFERATION; CHRONIC INFLAMMATION; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HEART DISEASE; HELICOBACTER INFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARKINSON DISEASE; PNEUMONIA; RICKETTSIA; T LYMPHOCYTE; ANIMAL; CHEMISTRY; CHRONIC DISEASE; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CHRONIC DISEASE; HUMANS; IMMUNE SYSTEM; INFLAMMATION;

EID: 84903740442     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557514666140428112602     Document Type: Article

References (99)

1. De Tullio, M.C. The Mystery of Vitamin C. Nature Education, 2010, 3(9), 48.
2. Telang, P.S. Vitamin C in dermatology. Indian Dermatol Online J., 2013, 4(2), 143-146.
3. Grosso, G.; Bei, R.; Mistretta, A.; Marventano, S.; Calabrese, G.; Masuelli, L.; Giganti, M.G.; Modesti, A.; Galvano, F.; Gazzolo, D. Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark Ed)., 2013, 18, 1017-29.
4. Strohle, A.; Wolters, M.; Hahn, A. Micronutrients at the Interface Between Inflammation and Infection Ascorbic Acid and Calciferol. Part 1: General Overview with a Focus on Ascorbic Acid. Inflamm Allergy Drug Targets, 2011, 10(1), 54-63.
5. Bohndiek, S.E.; Kettunen, M.I.; Hu, D.E.; Kennedy, B.W.; Boren, J.; Gallagher, F.A.; Brindle, K.M. Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in vivo. J Am Chem Soc., 2011, 133(30), 11795-801.
6. Padayatty, S.J.; Levine, M. New insights into the physiology and pharmacology of vitamin C. CMAJ., 2001, 164(3), 353-5.
7. Heller, R. Ascorbat. In: Dunkelberg, H.; Gebel, T.; Hartwig, A. (Hrsg.): Handbuch der Lebensmitteltoxikologie. Belastungen, Wirkungen, Lebensmittelsicherheit, Hygiene. Weinheim: Wiley-VCH, 2007, 2135-2162.
8. Kaelin, W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem., 2005, 74, 115-128.
9. Hausinnger, R.P. Fell/alpha-ketoglutarate-dependent hydroxylases and related enzymes. Crit. Rev. Biochem. Mol. Biol., 2004, 39(1), 21-68.
10. Siddiq, A.; Aminova, L.R.; Ratan, R.R. Prolyl 4-hydroxylase activity-responsive transcription factors: from hydroxylation to gene expression and neuroprotection. Front Biosci., 2008, 13, 2875-87.
11. Verrax, J.; Calderon, P.B. The controversial place of vitamin C in cancer treatment. Biochem Pharmacol., 2008, 76(12), 1644-52.
12. Takanaga, H.; Mackenzie, B.; Hediger, M. Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch., 2004, 447(5), 677-82.
13. Montel-Hagen, A.; Kinet, S.; Manel, N.; Mongellaz, C.; Prohaska, R.; Battini, J.; Delaunay, J.; Sitbon, M.; Taylor, N. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell., 2008, 132(6), 1039-48.
14. Gonzalez, M.J.; Miranda-Massari, J.R.; Mora, E.M.; Guzman, A.; Riordan, N.H.; Riordan, H.D.; Casciari, J.J.; Jackson, J.A.; Roman-Franco, A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther., 2005, 4(1), 32-44.
15. Golde, D.W. Vitamin C in cancer. Integr Cancer Ther., 2003, 2(2), 158-9.
16. Gallie, D.R. The role of L-ascorbic acid recycling in responding to environmental stress and in promoting plant growth. J. Exp. Bot., 2013, 64(2), 433-43.
17. Lutsenko, E.A.; Carcamo, J.M.; Golde, D.W. Vitamin C prevents DNA mutation induced by oxidative stress. J. Biol. Chem., 2002, 277(19), 16895-9.
18. Li, Y.; Schellhorn, H.E. New developments and novel therapeutic perspectives for vitamin C. J. Nutr., 2007, 137(10), 2171-84.
19. Combs, G.F, Jr. The Vitamins fourth edition. AP 2012.
20. Strohle, A.; Hahn, A. Vitamin C and immune function. Med. Monatsschr. Pharm., 2009, 32(2), 49-54.
21. Dolberg, O.J.; Elis, A.; Lishner, M. Scurvy in the 21st century. Isr Med. Assoc. J., 2010, 12(3), 183-4.
22. Jacob, R.A.; Kelley, D.S.; Pianalto, F.S.; Swendseid, M.E.; Henning, S.M.; Zhang, J.Z.; Ames, B.N.; Fraga, C.G.; Peters, J.H. Immunocompetence and oxidant defense during ascorbate depletion of healthy men. Am. J. Clin. Nutr., 1991, 54(6 Suppl), 1302S-1309S.
23. Naidu, K.A. Vitamin C in human health and disease is still a mystery? An overview. J. Nutr., 2003, 2, 7-18.
24. Bruunsgaard, H.; Poulsen, H.E.; Pedersen, B.K.; Nyyssonen, K.; Kaikkonen, J.; Salonen, J.T. Long-term combined supplementation with alpha-tocopherol and vitamin C have no detectable antiinflammatory effects in healthy men. J. Nutr., 2003, 133(4), 1170-3.
25. Calder, P.C.; Albers, R.; Antoine, J.M.; Blum, S.; Bourdet-Sicard, R.; Ferns, G.A.; Folkerts, G.; Friedmann, P.S.; Frost, G.S.; Guarner, F.; Lovik, M.; Macfarlane, S.; Meyer, P.D.; M'Rabet, L.; Serafini, M.; van Eden, W.; van Loo, J.; Vas Dias, W.; Vidry, S.; Winklhofer-Roob, B.M.; Zhao, J. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr., 2009, 1, S1-45.
26. Furuya, A.; Uozaki, M.; Yamasaki, H.; Arakawa, T.; Arita, M.; Koyama, A.H. Antiviral effects of ascorbic and dehydroascorbic acids in vitro. Int. J. Mol. Med., 2008, 22(4), 541-5.
27. Stephensen, C.B.; Marquis, G.S.; Jacob, R.A.; Kruzich, L.A.; Douglas, S.D.; Wilson, C.M. Vitamins C and E in adolescents and young adults with HIV infection. Am. J. Clin. Nutr., 2006, 83(4), 870-9.
28. Zhang, Z.W.; Farthing, M.J.G. Helicobacter Pylori and gastric malignancy: Importance of oxidants, antioxidants and other cofactors. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylor: Basic mechanisms to clinical cure. Kluwer Academic Publishers: London, 2000, 513-24.
29. Zhang, Z.W.; Patchett, S.E.; Perrett, D.; Domizio, P.; Farthing, M.J. Gastric alpha-tocopherol and beta-carotene concentrations in association with Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol., 2000, 12(5), 497-503.
30. Zhang, Z.W.; Farthing, M.J. The roles of vitamin C in Helicobacter pylori associated gastric carcinogenesis. Chin. J. Dig. Dis., 2005, 6(2), 53-58.
31. Kim, Y.; Kim, H.; Bae, S.; Choi, J.; Lim, S.Y.; Lee, N.; Kong, J.M.; Hwang, Y.I.; Kang, J.S.; Lee, W.J. Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-a/ß at the Initial Stage of Influenza A Virus (H3N2) Infection. Immune Netw., 2013, 13(2), 70-4.
32. Hwang, I.; Scott, J.M.; Kakarla, T.; Duriancik, D.M.; Choi, S.; Cho, C.; Lee, T.; Park, H.; French, A.R.; Beli, E.; Gardner, E.; Kim, S. Activation mechanisms of natural killer cells during influenza virus infection. PLoS One, 2012, 7(12), e51858.
33. Mantovani, A.; Romero, P.; Palucka, A.K.; Marincola, F.M. Tumour immunity: effector response to tumour and role of the microenvironment. Lancet, 2008, 371(9614), 771-83.
34. Costantini, S.; Capone, F.; Guerriero, E.; Castello, G. An approach for understanding the inflammation and cancer relationship. Immunol Lett., 2009, 126(1-2), 91-2.
35. Ichim, T.E.; Minev, B.; Braciak, T.; Luna, B; Hunninghake, R.; Mikirova, N.A.; Jackson, J.A.; Gonzalez, M.J.; Miranda-Massari, J.R.; Alexandrescu, D.T.; Dasanu, C.A.; Bogin, V.; Ancans, J.; Stevens, R.B.; Markosian, B.; Koropatnick, J.; Chen, C.S.; Riordan, N.H. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med., 2011, 4, 9-25.
36. Duchmann, R.; Kaiser, I.; Hermann, E. Mayet, W.; Ewe, K.; Meyer zum Buschenfelde K.H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol., 1995, 102(3), 448-455.
37. Shanahan, F. Crohn's disease. Lancet, 2002, 359(9300), 62-69.
38. Wendland, B.E.; Aghdassi, E.; Tam, C. Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am. J. Clin. Nutr., 2001, 74(2), 259-264.
39. Buffinton, G.D.; Doe, W.F. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic Res, 1995, 22(2), 131-143.
40. Aghdassi, E.; Wendland, B.E.; Steinhart, A.H. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. a randomized controlled trial. Am. J. Gastroenterol., 2003, 98(2), 348-353.
41. Dashdorj, A.; Jyothi, K.R.; Lim, S.; Jo. A.; Nguyen, M.N., Ha, J.; Yoon, K.S.; Kim, H.J.; Park, J.H. Murphy MP, Kim SS. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines. BMC Med., 2013, 6, 11:178.
42. Maki, M.; Collin, P. Coeliac disease. Lancet., 1997, 349(9067), 1755-9.
43. Sollid, L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol., 2002, 2(9), 647-55.
44. Bernardo, D.; Martinez-Abad, B.; Vallejo-Diez, S.; Montalvillo, E.; Benito, V.; Anta, B.; Fernandez-Salazar, L.; Blanco-Quiros, A.; Garrote, J.A. Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients. Arranz EAllergol Immunopathol (Madr.), 2012, 40(1), 3-8.
45. Schmidt, R.; Luboeinski, T.; Markart, P.; Ruppert, C.; Daum, C.; Grimminger, F.; Seeger, W.; Gunther, A. Alveolar antioxidant status in patients with acute respiratory distress syndrome. Eur Respir J,. 2004, 24(6), 994-9.
46. Kelly, F.J.; Mudway, I.; Blomberg, A. Altered lung antioxidant status in patients with mild asthma. Lancet, 1999, 354(9177), 482-483.
47. Jeong, Y.J.; Kim, J.H.; Kang, J.S.; Lee, W.J.; Hwang, Y.I. Megadose vitamin C attenuated lung inflammation in mouse asthma model. Anat. Cell Biol., 2010, 43(4), 294-302.
48. Romieu, I. Nutrition and lung health. Int. J. Tuberc. Lung Dis., 2005, 9(4), 362-74.
49. Devereux, G.; Turner, S.W.; Craig, L.C. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am. J. Respir. Crit. CareMed., 2006, 174(5), 499-507.
50. Tecklenburg, S.L.; Mickleborough, T.D.; Fly, A.D. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir. Med., 2007, 101(8), 1770-1778.
51. Biswas, S.; Hwang, J.W.; Kirkham, P.A.; Rahman, I. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease. Curr. Med. Chem., 2013, 20(12), 1496-530.
52. Wu, T.C.; Huang, Y.C.; Hsu, S.Y.; Wang, Y.C., Yeh, S.L. Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int. J. Vitam. Nutr. Res., 2007, 77(4), 272-9.
53. Rossman, M.J.; Garten, R.S.; Groot, H.J.; Reese, V.; Zhao, J.; Amann, M.; Richardson, R.S. Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2013, 305(10), R1163-70.
54. Helms, S.; Miller, A. Natural treatment of chronic rhinosinusitis. Altern. Med. Rev., 2006, 11(3), 196-207.
55. Unal, M.; Tamer, L.; Pata, Y.S.; Kilic, S.; Degirmenci, U.; Akbas, Y.; Gorur, K.; Atik, U. Serum levels of antioxidant vitamins, copper, zinc and magnesium in children with chronic rhinosinusitis. J. Trace. Elem. Med. Biol., 2004, 18(2), 189-92.
56. Helms, S.; Miller, A. Natural treatment of chronic rhinosinusitis. Altern. Med. Rev., 2006, 11(3), 196-207 review.
57. Fischer, H.; Schwarzer, C.; Illek, B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc. Natl. Acad. Sci. U.S.A., 2004, 101(10), 3691-6.
58. Bruckdorfer, K.R. Antioxidants and CVD. Proc. Nutr. Soc., 2008, 67, 214-222.
59. Wannamethee, S.G., Bruckdorfer, K.R.; Shaper, A.G.; Papacosta, O.; Lennon, L., Whincup, P.H. Plasma vitamin C, but not vitamin E, is associated with reduced risk of heart failure in older men. Circ. Heart Fail., 2013, 6, 647-54.
60. Singer, D.E.; Albers, G.W.; Dalen, J.E.; G, A.S.; Halperin, J.L.; Manning, W.J. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl.), 429S-456S.
61. Go, A.S.; Hylek, E.M.; Phillips, K.A.; Chang, Y.; Henault, L.E.; Selby, J.V.; Singer, D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA, 2001, 285(18), 2370-2375.
62. Boos, C.J.; Anderson, R.A.; Lip, G.Y. Is atrial fibrillation an inflammatory disorder? Eur Heart J., 2006, 27(2), 136-49.
63. Carnes, C.A.; Chung, M.K.; Nakayama, T.; Nakayama, H.; Baliga, R.S.; Piao, S.; Kanderian, A.; Pavia, S.; Hamlin, R.L.; McCarthy, P.M.; Bauer, J.A.; Van Wagoner, D.R. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res., 2001, 89(6), E32-8.
64. Korantzopoulos, P.; Kolettis, T.M.; Kountouris, E.; Dimitroula, V.; Karanikis, P.; Pappa E, Siogas K, Goudevenos, J.A. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int. J. Cardiol., 2005, 102(2), 321-326.
65. Aguirre, R.; May, J.M. Inflammation in the vascular bed: importance of vitamin C. Pharmacol. Ther., 2008, 119(1), 96-103.
66. Heo, J.H.; Hyon-Lee, Lee, K.M. The possible role of antioxidant vitamin C in Alzheimer's disease treatment and prevention. Am. J. Alzheimers Dis. Other Demen., 2013, 28(2), 120-5.
67. Rosales-Corral, S.; Tan, D.X.; Reiter, R.J. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res., 2003, 35(2), 80-84.
68. Huang, J.; May, J.M. Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by betaamyloid. Brain Res., 2006, 1097(1), 52-58.
69. Dhingra, D.; Parle, M.; Kulkarni, S.K. Comparative brain cholinesterase-inhibitng activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J. Med. Food., 2006, 9(2), 281-283.
70. Sutachan, J.J.; Casas, Z.; Albarracin, S.L., Stab, B.R. 2nd; Samudio, I., Gonzalez, J., Morales, L.; Barreto, G.E. Cellular and molecular mechanisms of antioxidants in Parkinson's disease. Nutr. Neurosci., 2012, 15(3), 120-6.
71. Fitzgerald, K.C., O'Reilly, E.J.; Fondell, E.; Falcone, G.J.; McCullough, M.L.; Park, Y., Kolonel, L.N.; Ascherio, A. Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies. Ann. Neurol., 2013, 73(2), 236-45.
72. Tavazzi, B.; Batocchi, A.P.; Amorini, A.M.; Nociti, V.; D'Urso, S.; Longo, S.; Gullotta, S., Picardi, M.; Lazzarino, G. Serum metabolic profile in multiple sclerosis patients. Mult. Scler. Int., 2011, 2011, 167156.
73. Besler, H.T.; Comoglu, S.; Okcu, Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci., 2002, 5(3), 215-20.
74. Moretti, M.; Budni, J.; Dos Santos, D.B.; Antunes, A.; Daufenbach, J.F.; Manosso, L.M.; Farina, M.; Rodrigues, A.L. Protective effects of ascorbic acid on behavior and oxidative status of restraint-stressed mice. J. Mol. Neurosci., 2013, 49(1), 68-79.
75. Amr, M.; El-Mogy, A.; Shams, T.; Vieira, K.; Lakhan, S.E.; Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. Nutr. J., 2013, 9, 12-31.
76. Powers, K.A.; Rehrig, S.T.; Jones D.B. Financial impact of obesity and bariatric surgery. Med. Clin. North Am., 2007, 91(3), 321-38.
77. Bray, G.A. Medical consequences of obesity. J. Clin. Endocrinol. Metab., 2004, 89(6), 2583-9.
78. Fantuzzi, G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol., 2005, 115(5), 911-9.
79. Ferrante, A.W. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med., 2007, 262(4) 408-14.
80. Yuan, M.; Konstantopoulos, N.; Lee, J.; Hansen, L.; Li, Z.W., Karin, M.; Shoelson, S.E. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikk-beta. Science, 2001, 293(5535), 1673-1677.
81. Cai, D.; Yuan, M.; Frantz, D.F.; Melendez, P.A.; Hansen, L.; Lee, J.; Shoelson, S.E. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature Medicine, 2005, 11(2), 183-190.
82. Fukuhara, A.; Matsuda, M.; Nishizawa, M.; Segawa, K.; Tanaka, M.; Kishimoto, K.; Matsuki, Y.; Murakami, M.; Ichisaka, T.; Murakami, H. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307 (5708), 426-430.
83. Haider, D.G.; Schindler, K.; Schaller, G.; Prager, G.; Wolzt, M.; Ludvik, B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J. Clin. Endocrinol. Metab., 2006, 91(4), 1578-1581.
84. Varma, V.; Yao-Borengasser, A.; Rasouli, N.; Bodles, A.M.; Phanavanh, B.; Lee, M.J.; Starks, T.; Kern, L.M.; Spencer, H.J.; McGehee, R.E. Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J. Clin. Endocrinol. Metab., 2007, 92(2), 666-672.
85. Martinez, J.A. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance. J. Physiol. Biochem., 2006, 62(4), 303-306.
86. Mutlu-Turkoglu, U.; Oztezcan, S.; Telci, A.; Orhan, Y.; Aykac-Toker, G.; Sivas, A.; Uysal, M. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women. Clin. Exp. Med., 2003, 2(4), 171-174.
87. Hasegawa, N.; Niimi, N.; Odani F. Vitamin C is one of the lipolytic substances in green tea. Phytother. Res., 2002, 16 Suppl 1, S91-92.
88. Senen, D.; Adanali, G.; Ayhan, M.; Gorgu M. & Erdogan B. Contribution of vitamin C administration for increasing lipolysis. Aesthetic Plast. Surg., 2002, 26(2), 123-125.
89. Garcia-Diaz, D.F.; Campion, J.; Milagro, F.I.; Paternain, L.; Solomon, A.; Martinez, J.A. Ascorbic acid oral treatment modifies lipolytic response and behavioural activity but not glucocorticoid metabolism in cafeteria diet fed rats. Acta Physiol. (Oxf), 2009, 195(4), 449-457.
90. Abdel-Wahab, Y.H.; O'Harte, F.P.; Mooney, M.H.; Barnett, C.R.; Flatt, P.R. Vitamin C supplementation decreases insulin glycation and improves glucose homeostasis in obese hyperglycemic (ob/ob) mice. Metabolism., 2002, 51(4) 514-517.
91. Carcamo, J.M.; Pedraza, A.; Borquez-Ojeda, O.; Golde, D.W. Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation. Biochemistry, 2002, 41(43), 12995-3002.
92. Garcia-Diaz, D.F.; Campion, J.; Milagro, F.I.; Boque, N.; Moreno-Aliaga, M.J.; Martinez, A. Vitamin C inhibits leptin secretion and some glucose/lipid metabolic pathways in primary rat adipocytes. J Mol. Endocrinol., 2010, 45(1), 33-43.
93. Arrigoni, O.; De Tullio, M.C. Ascorbic acid: much more than just an antioxidant. Biochim. Biophys. Acta., 2002, 1569(1-3), 1-9.
94. Patel, M.; McIntosh, L.; Bliss, T.; Ho, D.; Sapolsky, R. Interactions among ascorbate, dehydroascorbate and glucose transport in cultured hippocampal neurons and glia. Brain Res., 2001, 916(1-2), 127-35.
95. Garcia-Diaz, D.; Campion, J.; Milagro, F.I.; Martinez, J.A. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem., 2007, 305(1-2), 87-94.
96. Wroblewski, K.; Can the administration of large doses of vitamin C have a harmful effect? Pol. Merkur Lekarsk, 2005, 19(112), 600-3.
97. Ray, S.D.; Roy, P.P.; Ray, S. Sterodin, a novel immunostimulating drug: some toxicological and pharmacological evaluations in vivo, and drug-lipid interaction studies in vitro. Acta Pharm., 2009, 59(3), 325-34.
98. Candelario-Jalil, E.; Akundi, R.S.; Bhatia, H.S.; Lieb, K.; Appel, K.; Munoz, E.; Hull, M.; Fiebich, B.L. Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. J. Neuroimmunol., 2006, 174(1-2), 39-51.
99. Kara, Y.; Docuc, D.K.; Kulac, E.; Gultekin, F.; Acetylsalicylic Acid and Ascorbic Acid Combination Improves Cognition; Via Antioxidant Effect or Increased Expression of NMDARs and nAChRs? Envir. Toxicol. Pharmacol., 2014, S1382-6689(14), 00055-6.